There was a longer duration of neutropenia in the early G-CSF group, which is counterintuitive, but may reflect confounding by indication, i.e., patients with more severe hematologic toxicity necessitated earlier G-CSF treatment. The gene discussed is CSF3; the disease is Decreased total neutrophil count.